Invitation to presentation of BioArctic's first quarter report for January - March 2023 on April 27 at 9.30 a.m. CET

Rhea-AI Summary

BioArctic AB, listed as BIOA B on Nasdaq Stockholm, will release its first quarter report for January - March 2023 on April 27, 2023, at 08:00 a.m. CET.

The company will host an audiocast with teleconference at 09:30 CET on the same day, featuring CEO Gunilla Osswald and CFO Jan Mattsson. This session will include a presentation of the financial results followed by a Q&A segment.

Investors and analysts can participate via a webcast or teleconference by registering through the provided links. The presentation will be subsequently available on BioArctic's corporate website.

Positive

• Upcoming first quarter report expected to provide insights into financial performance.
• Audiocast offers an opportunity for direct engagement with the CEO and CFO.

Negative

• None.

News Market Reaction – BIOA

+11350.90%

+11350.90% Session move

In the trading session that priced this news, BIOA gained 11350.90%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

STOCKHOLM, April 19, 2023 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) will publish the company's first quarter report for January - March 2023 on Thursday, April 27, 2023, at 08:00 a.m. CET.

In conjunction to the report, BioArctic invites investors, analysts, and media to an audiocast with teleconference (in English) on April 27, at 09:30 CET, where Gunilla Osswald, CEO, and Jan Mattsson, CFO, will present BioArctic and comment on the first quarter report for January – March 2023, followed by a Q&A-session.

If you wish to participate via webcast, please use the link below. Via the webcast you are able to ask written questions.

Webcast: https://ir.financialhearings.com/bioarctic-q1-2023/register

If you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.

https://conference.financialhearings.com/teleconference/?id=200663

The webcast will also be available on demand on BioArctic's corporate website https://www.bioarctic.se/en/section/investors/presentations/ after the presentation.

For more information, please contact:
Oskar Bosson, VP Communications and Investor Relations, BioArctic AB
E-mail: oskar.bosson@bioarctic.se
Tel: + 46 704 10 71 80

This information was submitted for publication at 08:30 a.m. CET on April 19, 2023.

About BioArctic AB
BioArctic AB (publ) is a Swedish research-based biopharma company focusing on disease-modifying treatments and reliable biomarkers and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. BioArctic focuses on innovative treatments in areas with high unmet medical needs. The company was founded in 2003 based on innovative research from Uppsala University, Sweden. Collaborations with universities are of great importance to the company together with its strategically important global partner Eisai in Alzheimer disease. The project portfolio is a combination of fully funded projects run in partnership with global pharmaceutical companies and innovative in-house projects with significant market and out-licensing potential. BioArctic's Class B share is listed on Nasdaq Stockholm Large Cap (ticker: BIOA B). For more information about BioArctic, please visit www.bioarctic.com.

The following files are available for download:

https://mb.cision.com/Main/9978/3752639/1992960.pdf

Invitation to presentation of BioArctics First Quarter Results January - March 2023

 

View original content:https://www.prnewswire.com/news-releases/invitation-to-presentation-of-bioarctics-first-quarter-report-for-january---march-2023-on-april-27-at-9-30-am-cet-301801527.html

SOURCE BioArctic

FAQ

When will BioArctic publish its first quarter report for January - March 2023?

BioArctic will publish its first quarter report on April 27, 2023, at 08:00 a.m. CET.

What time is the audiocast for BioArctic's first quarter results?

The audiocast will take place on April 27, 2023, at 09:30 CET.

How can I participate in BioArctic's teleconference?

You can participate in BioArctic's teleconference by registering through the provided link prior to the event.

Who will present at BioArctic's first quarter report audiocast?

The presentation will be led by CEO Gunilla Osswald and CFO Jan Mattsson.